Lead, cadmium, and arsenic, toxic metals found in food, water, and the environment, present a serious threat to cardiovascular well-being in the United States. A scientific statement jointly released by multiple American Heart Association councils underscores the urgency of implementing regulatory measures to reduce population-level exposure to these harmful substances.
Exposure to toxic metals such as lead, cadmium, and arsenic can result in various cardiovascular complications, including atherosclerotic cardiovascular disease (ASCVD), electrocardiogram (ECG) abnormalities, stroke, and even death. These metals, once absorbed by the body, initiate molecular and cellular changes that impair endothelial function, cause chronic inflammation, and induce oxidative stress.
Historically underrepresented communities face a disproportionate burden of toxic metal exposure. Soil and water analyses reveal alarmingly high levels of lead, cadmium, and arsenic in these communities, primarily attributed to environmental hazards, inadequate regulation enforcement, and poor response to complaints. The presence of racial and ethnic disparities in exposure highlights the urgent need for targeted intervention and support.
Unveiling the Culprits: Common Sources of Toxic Metal Exposure
Lead, cadmium, and arsenic can enter our lives through various avenues. Outdated paint, tobacco products, contaminated food, water pipes, herbal remedies, cosmetics, electronics, industrial emissions, and heating systems contribute to lead exposure. Cadmium finds its way into nickel-cadmium batteries, pigments, ceramics, and even fertilizers used in agriculture. Inorganic arsenic, a known groundwater contaminant, lurks in private wells and can be found in rice, apple juice, and wine.
Toxic metals are readily absorbed through the respiratory and gastrointestinal tracts, with arsenic also capable of dermal absorption. While the gastrointestinal absorption of lead and cadmium depends on essential metals’ bioavailability and dietary sources, the respiratory tract allows almost complete absorption due to contaminated air penetrating the alveolar-capillary membrane. Once absorbed, lead accumulates in bones, while cadmium targets the kidneys, liver, and other organs, where these metals persist for extended periods.
A Call for Action: Identifying Biomarkers and Mitigating Exposure
The scientific statement suggests potential urine biomarkers for assessing toxic metal exposure, with recommended concentrations for lead, cadmium, and arsenic. Monitoring these levels can aid in identifying individuals at risk and initiating appropriate interventions. Measures to mitigate exposure include home drinking water filtration, air filters that target fine particulate matter, smoking cessation, and regular screening of lead, cadmium, and arsenic levels. Chelating drugs offer promise in removing these metals from the body.
Toxic metal exposure disproportionately affects marginalized communities, with racial and ethnic disparities evident in biomarker concentrations. Black, Hispanic, and Asian individuals often show higher levels of cadmium and lead compared to white counterparts. Lead-contaminated drinking water disproportionately impacts neighborhoods inhabited by historically underrepresented groups, while arsenic concentrations remain elevated in American Indian and Hispanic communities. Urgent attention and equitable interventions are necessary to rectify these environmental injustices.
The scientific statement from the American Heart Association serves as a clarion call to address the risks posed by toxic metal exposure on cardiovascular health. Public health efforts, policy changes, and regulatory measures are crucial for reducing population-level exposure, protecting marginalized communities, and improving overall cardiovascular outcomes. Recognizing toxic metals as reversible risk factors opens avenues for preventive strategies and medical interventions that can transform the lives of countless patients.
